| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
One of the 10 Largest CRO’s Signs a 5 Year GrantPlan
One of the 10 Largest CRO’s Signs a 5 Year GrantPlan
GrantPlan® Produces Better Grant Estimates, Proposal Preparation, and Cost Management
Philadelphia,
PA,
United States of America
(prbd.net)
09/11/2011
One of the 10 Largest CRO’s Signs a 5 Year GrantPlan® Agreement with TTC, LLC to Reduce Investigator Grant Development Time and Enhance Overall Efficiency
GrantPlan® Produces Better Grant Estimates, Proposal Preparation, and Cost Management
PHILADELPHIA, PA -- TTC, LLC today announced that one of the 10 largest CRO’s, recognized as a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies, has signed a contract to gain access to GrantPlan®, the largest database of current clinical investigator budgets. TTC now claims multiyear subscriptions with 10 of the largest CROs.
A top executive of this CRO observed that "GrantPlan® provides us with access to the current global clinical cost data that we use and need to reduce the time required to create investigator grant budgets, manage negotiations, and increase the confidence level of our customers. We opted for GrantPlan® to develop more informed and accurate investigator grant forecasts for both international and domestic customers. Through GrantPlan® we get better estimates in our proposals, and our contract negotiation team begins grant negotiations with better data. We have had an excellent response to date.”
As a Certified GrantPlan® customer, this CRO will have access to data collected from clinical studies in 60 countries from over 100 GrantPlan® subscribers. GrantPlan® will assist their business development team with proposal preparation and provide a more effective site start-up process by engaging the investigators sooner in the study process.
About GrantPlan® and TTC, LLC
GrantPlan®, a product of TTC, LLC, is the largest database of current clinical investigator budgets. With five distinctive database products, TTC has the largest current database of investigator site budgets from 60 countries. TTC combines a strong financial base, a global reach, and an experienced team of customer-focused professionals proud to serve the industry in the management of costs and speed of clinical trials. GrantPlan® contains extensive cost data at the Procedure, Cost per Visit, and Cost per Patient levels from countries involved in drug testing throughout North America, Europe, Asia and Latin America. For more information please visit www.ttc-llc.com.
For more information visit http://www.ttc-llc.com/OurProducts/GrantPlan.aspx or call us at 215-243-4103
About
TC is the leader in global clinical trial cost benchmarking. In fact, we invented it. In 1990, TTC principle, Dr. Harold E. Glass founded the first drug development cost benchmarking company in the world. Today, 10 year old TTC, with offices in Philadelphia, Pennsylvania and London, England has a proven track record in all aspects of outsourcing cost management; from the budgeting of protocols and clinical trials to the negotiations with clinical sites and other providers.
|